Non-hallucinogenic psychedelic development gets its first validated cellular screening tool: scientists identified a phosphoproteomic fingerprint that reliably separates hallucinogenic compounds like ...
EMA's September 2026 NAM data pilot lets sponsors share organ-chip and computational data directly with regulators, reshaping ...